These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 30905295)
61. Ma X; Wong AS; Tam HY; Tsui SY; Chung DL; Feng B Zool Res; 2018 Mar; 39(2):58-71. PubMed ID: 29515088 [TBL] [Abstract][Full Text] [Related]
62. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila. Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352 [TBL] [Abstract][Full Text] [Related]
63. The genome editing revolution: A CRISPR-Cas TALE off-target story. Stella S; Montoya G Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121 [TBL] [Abstract][Full Text] [Related]
64. Repurposing prokaryotic clustered regularly interspaced short palindromic repeats-Cas adaptive immune system to combat antimicrobial resistance. Devi V; Harjai K; Chhibber S Future Microbiol; 2023 May; 18():443-459. PubMed ID: 37317864 [TBL] [Abstract][Full Text] [Related]
65. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins. Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ mBio; 2018 Dec; 9(6):. PubMed ID: 30514786 [TBL] [Abstract][Full Text] [Related]
66. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice. Xu R; Wei P; Yang J Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567 [TBL] [Abstract][Full Text] [Related]
67. CRISPR-Cas Systems in Prokaryotes. Burmistrz M; Pyrć K Pol J Microbiol; 2015; 64(3):193-202. PubMed ID: 26638527 [TBL] [Abstract][Full Text] [Related]
68. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals. Mitsui R; Yamada R; Ogino H World J Microbiol Biotechnol; 2019 Jul; 35(7):111. PubMed ID: 31280424 [TBL] [Abstract][Full Text] [Related]
69. [CRISPR-Cas system as molecular scissors for gene therapy]. Heinz GA; Mashreghi MF Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743 [TBL] [Abstract][Full Text] [Related]
70. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications. Bhatia S; Pooja ; Yadav SK Int J Biol Macromol; 2023 May; 238():124054. PubMed ID: 36933595 [TBL] [Abstract][Full Text] [Related]
71. CRISPR-Based Technologies and the Future of Food Science. Selle K; Barrangou R J Food Sci; 2015 Nov; 80(11):R2367-72. PubMed ID: 26444151 [TBL] [Abstract][Full Text] [Related]
72. CRISPR-Cas systems of lactic acid bacteria and applications in food science. Cui Y; Qu X Biotechnol Adv; 2024; 71():108323. PubMed ID: 38346597 [TBL] [Abstract][Full Text] [Related]
73. Aquaculture as a source of empirical evidence for coevolution between CRISPR-Cas and phage. Hoikkala V; Almeida GMF; Laanto E; Sundberg LR Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180100. PubMed ID: 30905289 [TBL] [Abstract][Full Text] [Related]
74. Using the Endogenous CRISPR-Cas System of Baker PL; Orf GS; Kevershan K; Pyne ME; Bicer T; Redding KE Appl Environ Microbiol; 2019 Dec; 85(23):. PubMed ID: 31540988 [TBL] [Abstract][Full Text] [Related]
75. Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome. Lam KN; Spanogiannopoulos P; Soto-Perez P; Alexander M; Nalley MJ; Bisanz JE; Nayak RR; Weakley AM; Yu FB; Turnbaugh PJ Cell Rep; 2021 Nov; 37(5):109930. PubMed ID: 34731631 [TBL] [Abstract][Full Text] [Related]
76. CRISPR: a journey of gene-editing based medicine. Golkar Z Genes Genomics; 2020 Dec; 42(12):1369-1380. PubMed ID: 33094378 [TBL] [Abstract][Full Text] [Related]
77. Identification of Natural CRISPR Systems and Targets in the Human Microbiome. Münch PC; Franzosa EA; Stecher B; McHardy AC; Huttenhower C Cell Host Microbe; 2021 Jan; 29(1):94-106.e4. PubMed ID: 33217332 [TBL] [Abstract][Full Text] [Related]
78. Comparison of CRISPR and Marker-Based Methods for the Engineering of Phage T7. Grigonyte AM; Harrison C; MacDonald PR; Montero-Blay A; Tridgett M; Duncan J; Sagona AP; Constantinidou C; Jaramillo A; Millard A Viruses; 2020 Feb; 12(2):. PubMed ID: 32050613 [TBL] [Abstract][Full Text] [Related]
79. [Application of the CRISPR/Cas system in gene editing and nucleic acid detection of parasitic diseases: a review]. Yan S; Yang S; Yang H; Xin Y; Xu B; Hu W; Lu Y; Zheng B Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Jun; 36(3):314-320. PubMed ID: 38952320 [TBL] [Abstract][Full Text] [Related]
80. The evolving CRISPR technology. Yan M; Li J Protein Cell; 2019 Nov; 10(11):783-786. PubMed ID: 31243729 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]